Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONRC-05000623Phase 4Completed
Phase 4 trial of interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Roche. Primary endpoints: HBeAg-positive response and HBeAg-negative response. Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONRC-05000623.